Search results - 2 results
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe.
lung-transplanted (28.6; 95% CI: 22.7-35.5) non-lung-transplanted pwCF (16.6; 95% CI: 15.4-17.8) (p≤0.001). SARS-CoV-2 infection caused symptomatic illness in 75.7%. Factors associated with symptomatic SARS-CoV-2 ...
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study.
Kashirskaya, Nataliya; Edward McKone; Joel Melo; Middleton, Peter G; Pedro Mondejar-Lopez; de Monestrol, Isabelle; Nährlich, Lutz; Rita Padoan; Megan Parker; M Dolores Pastor-Vivero; Samar Rizvi; Rasa ...